文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

高龄红细胞与大量输血创伤患者死亡率和不良事件增加相关:PROPPR试验二次分析

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial.
PubMed 文献 · Ann Emerg Med · 2018-11-15
一句话结论在需大量输血的创伤患者中,每多输注1单位储存≥22天的红细胞与24小时死亡率独立相关(调整OR 1.05,95%CI 1.01-1.08),但该关联仅在输注≥10单位红细胞的患者中显著。

本研究为PROPPR试验的二次分析,纳入12家北美一级创伤中心678例预测需大量输血的危重创伤成人患者,共输注8830单位红细胞。主要暴露为住院24小时内输注的各储存时间分层红细胞容量,主要结局为24小时死亡率。多因素随机效应logistic回归显示,储存≥22天的红细胞单位数与24小时死亡率独立相关(调整OR 1.05/单位,95%CI 1.01-1.08),而0-7天、8-14天、15-21天组无显著关联。敏感性分析显示该关联仅在输注≥10单位红细胞的患者中相似,输注<10单位者无此关联。

要点

  • 在需大量输血(≥10单位红细胞)的创伤患者中,每多输1单位储存≥22天的红细胞,24小时死亡风险增加(调整OR 1.05,95%CI 1.01-1.08)。
  • 储存0-7天(OR 0.97,95%CI 0.88-1.08)、8-14天(OR 1.04,95%CI 0.99-1.09)、15-21天(OR 1.02,95%CI 0.98-1.06)的红细胞与24小时死亡率无显著关联。
  • 该关联仅在输注≥10单位红细胞的患者中一致,输注<10单位者未见此关联。
  • 678例患者共输注8830单位红细胞,100例(14.8%)在24小时内死亡。
  • 分析校正了总红细胞输注量、年龄、性别、种族、损伤机制、损伤严重度评分、修正创伤评分、临床中心及试验治疗组。

适用人群与场景

  • 纳入:PROPPR试验中12家北美一级创伤中心收治的危重创伤成人患者,至少接受1单位红细胞且预测需大量输血。

诊断标准与关键阈值

  • 主要暴露分层:住院24小时内输注的红细胞按储存时间分为0-7天、8-14天、15-21天、≥22天四类。
  • 大量输血定义:输注≥10单位红细胞(敏感性分析中用于分层)。

研究设计与关键结果

  • 研究类型:PROPPR试验的二次分析(随机对照试验数据二次分析),纳入678例患者,来自12家北美一级创伤中心。
  • 主要结局:24小时死亡率14.8%(100/678)。
  • 多因素分析:每输注1单位储存≥22天红细胞,24小时死亡率调整OR 1.05(95%CI 1.01-1.08);0-7天OR 0.97(95%CI 0.88-1.08);8-14天OR 1.04(95%CI 0.99-1.09);15-21天OR 1.02(95%CI 0.98-1.06)。
  • 敏感性分析:仅在输注≥10单位红细胞的患者中结果相似,输注<10单位者无此关联。

证据类型、等级与局限

  • 证据类型:随机对照试验(PROPPR)的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在需大量输血(≥10单位红细胞)的创伤患者中,输注较大量储存≥22天的红细胞与24小时死亡率增加相关,而输注<10单位者无此关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: The transfusion of older packed RBCs may be harmful in critically ill patients. We seek to determine the association between packed RBC age and mortality among trauma patients requiring massive packed RBC transfusion.

METHODS: We analyzed data from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios trial. Subjects in the parent trial included critically injured adult patients admitted to 1 of 12 North American Level I trauma centers who received at least 1 unit of packed RBCs and were predicted to require massive blood transfusion. The primary exposure was volume of packed RBC units transfused during the first 24 hours of hospitalization, stratified by packed RBC age category: 0 to 7 days, 8 to 14 days, 15 to 21 days, and greater than or equal to 22 days. The primary outcome was 24-hour mortality. We evaluated the association between transfused volume of each packed RBC age category and 24-hour survival, using random-effects logistic regression, adjusting for total packed RBC volume, patient age, sex, race, mechanism of injury, Injury Severity Score, Revised Trauma Score, clinical site, and trial treatment group.

RESULTS: The 678 patients included in the analysis received a total of 8,830 packed RBC units. One hundred patients (14.8%) died within the first 24 hours. On multivariable analysis, the number of packed RBCs greater than or equal to 22 days old was independently associated with increased 24-hour mortality (adjusted odds ratio [OR] 1.05 per packed RBC unit; 95% confidence interval [CI] 1.01 to 1.08): OR 0.97 for 0 to 7 days old (95% CI 0.88 to 1.08), OR 1.04 for 8 to 14 days old (95% CI 0.99 to 1.09), and OR 1.02 for 15 to 21 days old (95% CI 0.98 to 1.06). Results of sensitivity analyses were similar only among patients who received greater than or equal to 10 packed RBC units.

CONCLUSION: Increasing quantities of older packed RBCs are associated with increased likelihood of 24-hour mortality in trauma patients receiving massive packed RBC transfusion (≥10 units), but not in those who receive fewer than 10 units.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jones AR, Patel RP, Marques MB, et al. Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial. Ann Emerg Med. 2018. PMID: 30447946. doi:10.1016/j.annemergmed.2018.09.033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。